Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.

Oncogene·2015
Same author

ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.

Oncogene·2015
Same author

CTGF is a therapeutic target for metastatic melanoma.

Oncogene·2013
Same author

Genetically modified clostridium for gene therapy of tumors.

Methods in molecular medicine·2011
Same author

The role of hypoxia-inducible factors in tumorigenesis.

Cell death and differentiation·2008
Same author

The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.

Clinical cancer research : an official journal of the American Association for Cancer Research·2004
Same journal

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition, regardless of HRR status.

British journal of cancer·2026
Same journal

Oligometastatic neuroendocrine tumors: characteristics and prognosis.

British journal of cancer·2026
Same journal

The concept of functional cure in advanced/metastatic melanoma treated with combined nivolumab and ipilimumab or nivolumab alone.

British journal of cancer·2026
Same journal

Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

British journal of cancer·2026
Same journal

Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

British journal of cancer·2026
Same journal

Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

British journal of cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

PHD2 in tumour angiogenesis.

D A Chan1, A J Giaccia

  • 1Department of Radiation Oncology, University of California, 2340 Sutter Street, S-332, Box 1331, San Francisco, CA 94143-1331, USA.

British Journal of Cancer
|May 13, 2010
PubMed
Summary
This summary is machine-generated.

Prolyl hydroxylase domain (PHD) proteins, particularly PHD2, are crucial for regulating hypoxia-inducible factor (HIF). This review explores PHD2

More Related Videos

Isolation and Culture Expansion of Tumor-specific Endothelial Cells
10:15

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
12:09

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Related Experiment Videos

Last Updated: Jun 13, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Isolation and Culture Expansion of Tumor-specific Endothelial Cells
10:15

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
12:09

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics

Published on: June 16, 2013

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Prolyl hydroxylase domain (PHD) proteins regulate hypoxia-inducible factor-1alpha (HIF-1alpha) stability.
  • PHD2 is identified as a key oxygen sensor, with its knockdown leading to elevated HIF protein levels.
  • Recent research underscores the significance of PHD2 in tumorigenesis, but its precise role in tumor angiogenesis remains debated.

Purpose of the Study:

  • To review the current understanding of PHD2's role in tumor angiogenesis.
  • To clarify the conflicting evidence regarding PHD2's function in tumor vascularization.
  • To differentiate the contributions of tumor-derived versus stromal-derived PHD2, especially in endothelial cells.

Main Methods:

  • Literature review of recent studies on PHD2 and tumor angiogenesis.
  • Analysis of conflicting data concerning PHD2's impact on vascular normalization and neovascularization.
  • Focus on the cellular origins of PHD2 (tumor vs. stroma) and their respective roles.

Main Results:

  • PHD2 plays a complex role in tumor angiogenesis, influenced by its cellular source.
  • Evidence suggests PHD2 from tumor cells and stromal cells, particularly endothelial cells, have distinct effects.
  • Understanding these distinctions is key to resolving conflicting findings on PHD2's function.

Conclusions:

  • PHD2's role in tumor angiogenesis is context-dependent, varying with its cellular origin.
  • Further research is needed to elucidate the specific mechanisms by which tumor- and stromal-derived PHD2 influence vascular normalization and neovascularization.
  • Clarifying these roles could offer new therapeutic strategies targeting tumor angiogenesis.